RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,577,979 | -29.8% | 1,970,988 | +4.8% | 0.00% | -33.3% |
| Q2 2023 | $23,628,633 | -18.2% | 1,881,260 | +7.2% | 0.00% | -25.0% |
| Q1 2023 | $28,897,120 | +114072.7% | 1,754,530 | +3.6% | 0.00% | 0.0% |
| Q4 2022 | $25,310 | -99.9% | 1,694,121 | +9.2% | 0.00% | -20.0% |
| Q3 2022 | $34,695,000 | +45.2% | 1,550,975 | +8.7% | 0.01% | +25.0% |
| Q2 2022 | $23,897,000 | -41.0% | 1,426,724 | +5.5% | 0.00% | -20.0% |
| Q1 2022 | $40,479,000 | +1.0% | 1,352,477 | +3.6% | 0.01% | 0.0% |
| Q4 2021 | $40,077,000 | +19.3% | 1,305,016 | +22.5% | 0.01% | 0.0% |
| Q3 2021 | $33,587,000 | +29.7% | 1,065,260 | +50.5% | 0.01% | +25.0% |
| Q2 2021 | $25,901,000 | +24.1% | 707,895 | +17.2% | 0.00% | +33.3% |
| Q1 2021 | $20,877,000 | +12.6% | 603,933 | +35.4% | 0.00% | 0.0% |
| Q4 2020 | $18,536,000 | -0.4% | 446,024 | +2.1% | 0.00% | -25.0% |
| Q3 2020 | $18,611,000 | – | 436,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |